Natco Pharma Gets USFDA’s Final Approval For Generic Azacitidine


On Tuesday Natco Pharma has received final approval of ANDA (Abbreviated New Drug Application) for azacitidine for injection; 100 mg per vial, single dose vial a generic version of videos by Celgene Corporation.

The Natco pharma company is one of the pharmaceutical company which help in developing, marketing and manufacturing FDF (Finished Dosage Formulation) and API’S (Active Pharmaceutical Ingredients) Natco with its marketing partner Breckenridge pharmaceutical, Inc is planning to launch this product in the US market in the near future.

Myelodysplastic syndrome (MDS) is treated by video, is a prescription anti-cancer chemotherapy drug. it has generated total combined sales of USD 188 million for the 12 month period ending April, 2017 based on industry sales data.

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔
Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: